Literature DB >> 17103066

Quality of life after bilateral prophylactic mastectomy.

Ann M Geiger1, Larissa Nekhlyudov, Lisa J Herrinton, Sharon J Rolnick, Sarah M Greene, Carmen N West, Emily L Harris, Joann G Elmore, Andrea Altschuler, In-Liu A Liu, Suzanne W Fletcher, Karen M Emmons.   

Abstract

BACKGROUND: Bilateral prophylactic mastectomy in women with increased breast cancer risk dramatically reduces breast cancer occurrence but little is known about psychosocial outcomes.
METHODS: To examine long-term quality of life after bilateral prophylactic mastectomy, we mailed surveys to 195 women who had the procedure from 1979 to 1999 and to a random sample of 117 women at increased breast cancer risk who did not have the procedure. Measures were modeled on or drawn directly from validated instruments designed to assess quality of life, body image, sexuality, breast cancer concerns, depression, health perception, and demographic characteristics. We used logistic regression to examine associations between quality of life and other domains.
RESULTS: The response rate was 58%, with 106 women with and 62 women without prophylactic mastectomy returning complete surveys. Among women who underwent bilateral prophylactic mastectomy, 84% were satisfied with their decision to have the procedure; 61% reported high contentment with quality of life compared with an identical 61% of women who did not have the procedure (P = 1.0). Among all subjects, diminished contentment with quality of life was not associated with bilateral prophylactic mastectomy but with dissatisfaction with sex life (adjusted ratio [OR] = 2.5, 95% confidence interval [CI] = 1.0-6.2), possible depression (CES-D > 16, OR = 4.9, CI = 2.0-11.8), and poor or fair general health perception (OR = 8.3, 95% CI = 2.4-29.0).
CONCLUSIONS: The majority of women reported satisfaction with bilateral prophylactic mastectomy and experienced psychosocial outcomes similar to women with similarly elevated breast cancer risk who did not undergo prophylactic mastectomy. Bilateral prophylactic mastectomy appears to neither positively nor negatively impact long-term psychosocial outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 17103066     DOI: 10.1245/s10434-006-9206-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

Review 1.  United States trends in the surgical treatment of primary breast cancer.

Authors:  Todd M Tuttle; Natasha M Rueth; Andrea Abbott; Beth A Virnig
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

2.  Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support Intervention.

Authors:  D St-Pierre; K Bouchard; L Gauthier; J Chiquette; Michel Dorval
Journal:  J Genet Couns       Date:  2017-09-15       Impact factor: 2.537

Review 3.  BRCA mutation testing in determining breast cancer therapy.

Authors:  Karen Lisa Smith; Claudine Isaacs
Journal:  Cancer J       Date:  2011 Nov-Dec       Impact factor: 3.360

4.  Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.

Authors:  Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A Price
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

5.  Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.

Authors:  Dirk Müller; Marion Danner; Kerstin Rhiem; Björn Stollenwerk; Christoph Engel; Linda Rasche; Lisa Borsi; Rita Schmutzler; Stephanie Stock
Journal:  Eur J Health Econ       Date:  2017-04-05

Review 6.  Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes.

Authors:  Shantanu N Razdan; Vishal Patel; Sarah Jewell; Colleen M McCarthy
Journal:  Qual Life Res       Date:  2015-11-14       Impact factor: 4.147

7.  Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.

Authors:  Jennifer K Litton; Shannon N Westin; Kaylene Ready; Charlotte C Sun; Susan K Peterson; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Diane C Bodurka; Karen H Lu; Gabriel N Hortobagyi; Banu K Arun
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

8.  Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy.

Authors:  Andrea F Patenaude; Sara Orozco; Xiaochun Li; Carolyn M Kaelin; Michelle Gadd; Yvedt Matory; Kathleen Mayzel; Constance A Roche; Barbara L Smith; Walden Farkas; Judy E Garber
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

Review 9.  BRCA1/2 associated hereditary breast cancer.

Authors:  Li-song Teng; Yi Zheng; Hao-hao Wang
Journal:  J Zhejiang Univ Sci B       Date:  2008-02       Impact factor: 3.066

10.  Innovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients.

Authors:  Linden Head; Carolyn Nessim; Kirsty Usher Boyd
Journal:  Can J Surg       Date:  2017-02       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.